HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An immunohistochemical study of helix pomatia agglutinin binding on carcinomas of the esophagus.

Abstract
In many factors affecting the biologic behavior of malignant cells, alterations in the carbohydrate composition of cell membrane glycoproteins and glycolipids are considered to underlie the changes in cell adhesion that accompany malignant transformation and the development of invasive and metastatic properties. We investigated the alterations of the cell surface glycoproteins structure of carcinoma of the esophagus cells by HPA staining. The rate of patients with positive HPA staining increases with progression of depth of carcinoma invasion and venous invasion, and the survival in patients with positive HPA was poorer than in those with negative HPA. HPA-positive cells of carcinoma of the esophagus represent high malignant potentials. The HPA staining method is available to predict the prognosis of patients with carcinoma of the esophagus.
AuthorsY Yoshida, T Okamura, T Shirakusa
JournalSurgery, gynecology & obstetrics (Surg Gynecol Obstet) Vol. 177 Issue 3 Pg. 299-302 (Sep 1993) ISSN: 0039-6087 [Print] United States
PMID7689253 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Helix lectin
  • Lectins
  • Acetylgalactosamine
  • Acetylglucosamine
Topics
  • Acetylgalactosamine (metabolism)
  • Acetylglucosamine (metabolism)
  • Aged
  • Carcinoma, Squamous Cell (metabolism, mortality, pathology)
  • Esophageal Neoplasms (metabolism, mortality, pathology)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lectins (metabolism)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness (pathology)
  • Neoplasm Staging
  • Prognosis
  • Staining and Labeling
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: